Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours Β· Estimated delivery Aug 17 - Aug 22
Clinical studies used doses in the 90 to 300 mcg range with consistent improvements in delta-wave sleep
This is mechanistically demonstrated in breast cancer models, where SFN, by activating the Nrf2 pathway, reduces the secretion of prostaglandin E2 (PGE2) from tumor cells, thereby triggering MDSCs to switch from an immunosuppressive to an immunogenic phenotype and inhibiting their expansion (76)
Metastatic ER+ breast cancer: mechanisms of resistance and future therapeutic approaches
Is a Certificate of Analysis included with every order
US$ 23.88
US$ 26.04
US$ 22.00
US$ 25.79
